Guanhao Biotech Co Ltd Financial Flexibility Index
Guanhao Biotech Co Ltd financial flexibility index. Guanhao Biotech Co Ltd (300238) has a Financial Flexibility Index of 0.09x as of December 2025. Free cash flow of CN¥27.42 Million (operating CF CN¥18.84 Million minus capex CN¥8.58 Million) represents 0% of total liabilities (CN¥300.50 Million). Explore 300238 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guanhao Biotech Co Ltd (2007–2025)
Financial flexibility index of Guanhao Biotech Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Guanhao Biotech Co Ltd across 19 annual periods. Check how aggressively does Guanhao Biotech Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Guanhao Biotech Co Ltd Financial Flexibility Index by Year (2007–2025)
Guanhao Biotech Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Guanhao Biotech Co Ltd. For the full cash flow conversion analysis, see 300238 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | CN¥109.64 Million | CN¥71.47 Million | CN¥300.50 Million | ▼ -16.8% |
| 2024 | 0.44x | CN¥125.76 Million | CN¥49.55 Million | CN¥286.81 Million | ▼ -9.8% |
| 2023 | 0.49x | CN¥108.07 Million | CN¥54.15 Million | CN¥222.33 Million | ▲ +3.7% |
| 2022 | 0.47x | CN¥112.16 Million | CN¥70.98 Million | CN¥239.33 Million | ▲ +29.3% |
| 2021 | 0.36x | CN¥127.11 Million | CN¥122.39 Million | CN¥350.58 Million | ▲ +42.0% |
| 2020 | 0.26x | CN¥106.74 Million | CN¥103.84 Million | CN¥418.07 Million | ▲ +15.0% |
| 2019 | 0.22x | CN¥98.87 Million | CN¥92.55 Million | CN¥445.21 Million | ▲ +62.9% |
| 2018 | 0.14x | CN¥65.92 Million | CN¥32.28 Million | CN¥483.57 Million | ▲ +34.8% |
| 2017 | 0.10x | CN¥51.10 Million | CN¥19.22 Million | CN¥505.25 Million | ▼ -75.4% |
| 2016 | 0.41x | CN¥94.86 Million | CN¥30.68 Million | CN¥230.93 Million | ▼ -12.0% |
| 2015 | 0.47x | CN¥87.05 Million | CN¥67.87 Million | CN¥186.41 Million | ▼ -56.7% |
| 2014 | 1.08x | CN¥94.86 Million | CN¥65.45 Million | CN¥87.92 Million | ▼ -4.7% |
| 2013 | 1.13x | CN¥84.18 Million | CN¥41.49 Million | CN¥74.36 Million | ▼ -17.5% |
| 2012 | 1.37x | CN¥120.58 Million | CN¥49.12 Million | CN¥87.88 Million | ▼ -10.3% |
| 2011 | 1.53x | CN¥96.74 Million | CN¥35.45 Million | CN¥63.27 Million | ▲ +107.5% |
| 2010 | 0.74x | CN¥67.06 Million | CN¥33.76 Million | CN¥91.03 Million | ▼ -15.7% |
| 2009 | 0.87x | CN¥39.63 Million | CN¥5.55 Million | CN¥45.34 Million | ▼ -22.9% |
| 2008 | 1.13x | CN¥28.14 Million | CN¥4.80 Million | CN¥24.81 Million | ▲ +191.0% |
| 2007 | 0.39x | CN¥7.81 Million | CN¥1.73 Million | CN¥20.03 Million | — |